Archives des Réduction des méfaits - Page 2 sur 2

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients’, community organization and healthcare workers’ perspectives

Bédard K, Boisvert I, Rochette M, Racine E, Martel-Laferrière V. BMC Infect Dis. 2025 Feb 14;25(1):221. doi: 10.1186/s12879-025-10617-y. PMID: 39953410; PMCID: PMC11829365. CONSULTER

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients’, community organization and healthcare workers’ perspectives Lire la suite »

Réduction des méfaits

The Effect of Opioid Agonist Treatment on Injection-Related Sequelae: A Population-Based Observational Study

A protocol for high-dose lisdexamfetamine and contingency management, alone or in combination, for the treatment of methamphetamine use disorder: The ASCME study

The effects of a provincial opioid prescribing standard on prescribing for pain in adults: an interrupted time-series analysis

Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients’, community organization and healthcare workers’ perspectives

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study

Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022

MENU

CONTACT

Centre de Recherche du CHUM

Téléphone

Courriel